{
  "compound": "CBD",
  "condition": "DEPRESSION",
  "effect_size": "Large (Cohen's d = 0.89 for depression)",
  "study_type": "OBSERVATIONAL",
  "source": "NORML:DEPRESSION_OBSERVATIONAL_013",
  "participants": "187 CKD patients (stages 3-5) with depression",
  "year": 2020,
  "notes": "Cannabidiol for Depression in Chronic Kidney Disease: Nephrology Cohort Study",
  "confidence": "medium",
  "abstract": "BDI-II reduced 41% (22.7 \u2192 13.4); KDQOL improved 38%; no worsening of kidney function (eGFR stable)"
}